文献速递皮肤肿瘤

着色性干皮病的新型治疗方法

Novel therapeutic approaches to xeroderma pigmentosum.
PubMed 文献 · Br J Dermatol · 2018-11-25

本文综述着色性干皮病的临床表现、分子机制和当前管理,重点讨论针对核苷酸切除修复缺陷下游代谢缺陷的新型治疗策略。细胞模型显示特定磺脲类药物促进DNA损伤清除并增加对紫外线的抵抗,烟酰胺减轻紫外线对细胞的影响,热量限制减少动物模型中的DNA损伤负荷。目前临床管理仍以预防性避光为主,而非改善病情的疗法,因此需要新型方法。

要点

  • 着色性干皮病临床管理仍以预防性避光为主,而非改善病情的疗法。
  • 特定磺脲类药物在着色性干皮病细胞模型中促进DNA损伤清除并增加对紫外线的抵抗。
  • 烟酰胺减轻紫外线对细胞的影响,热量限制减少着色性干皮病动物模型中的DNA损伤负荷。

核心结论

  • 着色性干皮病患者的临床管理仍侧重于预防性避光,而非改善病情的疗法,因此需要新型方法。

研究设计与样本

  • 本文为综述,讨论着色性干皮病的新型治疗方法,聚焦核苷酸切除修复下游的代谢缺陷。

主要发现

  • 特定磺脲类药物在着色性干皮病细胞模型中促进DNA损伤清除并增加对紫外线的抵抗。
  • 烟酰胺减轻紫外线对细胞的影响。
  • 热量限制减少着色性干皮病动物模型中的DNA损伤负荷。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries. OBJECTIVES: This review aims to cover clinical presentation, molecular mechanisms and current management, and highlights more recent insights into targeting the deficiencies secondary to the DNA repair defects to prevent skin cancer and/or neurological degeneration. METHODS: This review article discusses novel therapeutic approaches to xeroderma pigmentosum that focus on metabolic defects downstream of nucleotide excision repair. RESULTS: Current research demonstrates that specific sulfonylureas promote clearance of DNA damage and increase resistance to ultraviolet radiation in a cellular model of xeroderma pigmentosum. Moreover, nicotinamide attenuates the effects of ultraviolet radiation in cells, and caloric restriction decreases DNA damage burden in animal models of xeroderma pigmentosum. CONCLUSIONS: Clinical management of patients with xeroderma pigmentosum still focuses on preventative avoidance of sun exposure as opposed to therapies that would improve the patients' condition; thus, novel approaches to this disease are warranted.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Weon JL, Glass DA. Novel therapeutic approaches to xeroderma pigmentosum. Br J Dermatol. 2018. PMID: 30265743. doi:10.1111/bjd.17253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。